demonstrated similar effects that were not suppressed by reserpine, propranolol, or phentolamine, thereby suggesting a direct mode of action [3234]
When someone first starts treatment with a GLP-1 receptor agonist, we slowly introduce the medication for a reason theres a risk of gastrointestinal side effects as your body gets used to the drug
These numbers underscore the critical necessity for new solutions
In combination with intensive behavioral therapy for weight loss, individuals (total n=611) in another study (note: funded by Novo-Nordisk) on semaglutide lost 16% of their body weight compared to 5.7% in the placebo control group
Clarification, April 1, 4:15 pm ET: A previous version of this post referred to the semaglutide revolution. The story has been updated to clarify that not all the medications for weight loss discussed are semaglutides.
If you are currently on a compounded GLP-1 or are considering starting medical weight loss, we are happy to discuss your options and determine the safest path forward